The ROE (Return on Equity) of Venus Medtech Hangzhou Inc (2500.HK) is -32.31%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -32.31% |
| 2023-12-31 | -24.10% |
| 2022-12-31 | -29.32% |
| 2021-12-31 | -8.22% |
| 2020-12-31 | -4.77% |
| 2019-12-31 | -12.54% |
| 2018-12-31 | -65.09% |
| 2017-12-31 | -216.53% |